JTKidney

The number of apheresis procedures to treat immune-mediated neurological diseases is on the rise Apheresis is used for the treatment of many different diseases, especially when conventional therapy lacks efficacy. There are however some diseases in which apheresis is accepted as first line therap...

New data from the World apheresis registry show an increase in #apheresis procedures for neurological diseases. While the total number of procedures did not increase #myasthenia gravis, #Guillain-Barré Syndrome, #multiple sclerosis, #CIDP and #NMOSD were on the rise.
www.trasci.com/article/S147...

Next session @ #ISFA 2025 on liver failure.

Hope that one day we can synchronize #apheresis therapy as perfectly as the artists synchronize dancing and percussion during the opening ceremony of the 15th #ISFA World Congress.

Ranistha Ratanarat giving a comprehensive overview of adsorptive trechnologiea in #sepsis at #ISFA 2025.

#sepsis remains one of the areas with the highest research activity on extracorporeal techniques but with the lowest number of positive RCTs. Excellent overview by Rasheed A. Balogun at #ISFA 2025.

Getting ready for #ISFA world congress of apheresis.

A happy moment, not only for Falko Mohrs, Minister of Science and Innovation and Mayor of Braunschweig Dr. Thorsten Kornblum but especially for pharmacy students at @tu-braunschweig.de that will enjoy the new building fro 2027 on. Teaching and science in pharmacy have a new home.

A firework of mechanistic data by @rebeccaherzog.bsky.social on how negative effects of glucose in #peritoneal dialysis could be attenuated.

Kerstin Amann from @fau.de presenting data from the #GRIP There are almost 2,500 peritoneal samples waiting to be analyzed. I am confident that the 1st International Meeting on Cellular and Molecular Peritoneal Dialysis Research will help foster collaboration in getting this done.

@ms-balzer.bsky.social with great slides and even better content talking about single-cell transscriptomics at 1st International Meeting on Cellular and Molecular Peritoneal Dialysis Research.

Switching gears and going from genetics to epigenetics with Raffaele Strippoli at 1st International Meeting on Cellular and Molecular Peritoneal Dialysis Research.

@er-goffin.bsky.social giving an excellent overview about what effect genetic variants have on the peritoneum. Another highlight at the 1st International Meeting on Cellular and Molecular Peritoneal Dialysis Research in Kiel.

Simon Davies kicking off day 2 of the 1st International Meeting on
Cellular and Molecular Peritonial Dialysis Research in Kiel.

@iottgroup.bsky.social explaining metallodrugs in #oncology at our #PJ-academy - a joined teaching module of PharmD & MD students at the @tu-braunschweig.de.

Phil Dera für DIE ZEIT

It had been a pleasure to start this week with @zeit.de for research. Discussing with Isabelle Jordans and Jörg Latus what „you snooze you loose“ means in the context of #CKD.

His mentor was Dr. Kolff, the inventor of the first working artificial kidney and he is still restless persuing innovative
projects - Prof. Dr. Dr. h.c.mult. Horst Klinkmann.

@jf60.bsky.social back to his alma mater #MHH giving an update on IgAN at #Dialyse-Update Hannover 2025.

Happy to share this slide presented by #ERA President Roser Torra at #ERA25 with the team of German minister of health Nina Warken @bmg-bund.bsky.social. I am looking forward to the support of the @bmg-bund.bsky.social for World Kidney Day March 9th 2026. We need a „Gesunde-Niere-Gesetz“.

Had been a pleasure for the Braunschweig team to meet @nephroseeker.medsky.social at #ERA25.

CKD5D remains non-adherent to our wishes when it comes to mortality reduction by MRA. Will #finrenone be more efficient?

Great #ACHIEVE ment by @lastwalsh.bsky.social and colleagues presented at the #ERA25. An important study that will hopefully be published accordingly.

Forget about it - the dip (after starting SGLT-2i) nicely played tune at the #ERA25.

Appraise for the interim analysis of the #VISIONARY trial in IgAN at #ERA25

Rarely seen at meetings - applause in the middle of a presentation 👏 this was the slide where it happened.
Have CONFIDENCE in combining Finrenone with SGLT-2i.

Mission impossible XI. Factor XI inhibition with MK-2060 does not prevent arteriovenous graft thrombosis in haemodialysis patients (but increases bleeding complications).

Don’t look any further. If you want to understand the background, technical aspects and future development of Lipoprotein Apheresis just listen to the excellent talk of Tina Khan at #ERA25.

No better place than Vienna to kick off a talk on ABOi renal transplantation with Landsteiner at #ERA25.

Florence in Vienna- excellent overview on AAV by @brixsilke.bsky.social at #ERA25.

Not surprised that the CON #AI view starts with the main EU regulations = hurdles for innovation.

Great talk by Dr. Len Usvyat at #ERA2025 on #AI in #nephrology